Profound Medical (Nasdaq:PROF) announced today that it sold shares of common stock worth proceeds of up to $40 million.

Transcatheter heart valve repair and replacement have reshaped how structural heart disease is treated, and the market is ...

Neurable announced that it closed a $35 million Series A to accelerate the commercialization of its brain-computer interface ...

Zoll announced today that it launched its next-generation LifeVest wearable cardioverter defibrillator (WCD) in the U.S.

Johnson & Johnson MedTech today announced its sponsorship of a new PFA data collection platform from the Heart Rhythm Society ...

Medline (Nasdaq:MDLN) announced today that it closed its upsized initial public offering (IPO) worth more than $8 billion.

Owens & Minor (NYSE:OMI) announced today that it is changing its name to Accendra Health to reflect its future organizational ...

Earlier this month, Medtronic said the FDA granted the indication for its Onyx liquid embolic system (LES) in the U.S. Onyx ...

Abbott (NYSE: ABT) received FDA clearance for its Amplatzer Piccolo delivery system for use with the Amplatzer Piccolo ...

Pulse Biosciences announced today that the FDA granted investigational device exemption (IDE) for a pulsed field ablation (PFA) study.

Science Corp. — better known for its brain-computer interface work — is in the early stages of reimagining extracorporeal ...

“I am grateful for Eileen’s leadership as interim CEO, and the continued dedication of Paula Newell, founder & board director ...